UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 272

Sortiert nach

Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma: comment

Journal of thrombosis and haemostasis, 2016-12, Vol.14 (12), p.2561-2562

Pengo, V.

2016

Volltextzugriff (PDF)

ISTH guidelines on Lupus Anticoagulant testing

Thrombosis research, 2012-10, Vol.130, p.S76-S77

Pengo, V.

2012

Volltextzugriff (PDF)

Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2018-04, Vol.16 (4), p.809-813

2018

Volltextzugriff (PDF)

Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

Lupus, 2011-02, Vol.20 (2), p.206-218

2011

Volltextzugriff (PDF)

Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk

Journal of thrombosis and haemostasis, 2015-05, Vol.13 (5), p.782-787

2015

Volltextzugriff (PDF)

Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants

Journal of thrombosis and haemostasis, 2018-05, Vol.16 (5), p.842-848

2018

Volltextzugriff (PDF)

Antiphospholipid syndrome: interpretation of laboratory data

Journal of thrombosis and haemostasis, 2011-02, Vol.9 (2), p.402-403

PENGO, V.

2011

Volltextzugriff (PDF)

ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study

International journal of cardiology, 2024-01, Vol.394, p.131369-131369, Article 131369

2024

Volltextzugriff (PDF)

Update of the guidelines for lupus anticoagulant detection

Journal of thrombosis and haemostasis, 2009-10, Vol.7 (10), p.1737-1740

2009

Volltextzugriff (PDF)

Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment

Journal of internal medicine, 2011-08, Vol.270 (2), p.110-122

2011

Volltextzugriff (PDF)

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2010-02, Vol.8 (2), p.237-242

2010

Volltextzugriff (PDF)

Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial

Lupus, 2016-03, Vol.25 (3), p.301-306

2016

Volltextzugriff (PDF)

The role of platelets in antiphospholipid syndrome

Platelets (Edinburgh), 2017-11, Vol.28 (8), p.762-766

2017

Volltextzugriff (PDF)

McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2018-08, Vol.16 (8), p.1656-1664

2018

Volltextzugriff (PDF)

The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study

Journal of thrombosis and haemostasis, 2009-11, Vol.7 (11), p.1767-1773

2009

Volltextzugriff (PDF)

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism

Journal of thrombosis and haemostasis, 2018-10, Vol.16 (10), p.1994-2002

2018

Volltextzugriff (PDF)

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study

Journal of thrombosis and haemostasis, 2016-11, Vol.14 (11), p.2194-2201

2016

Volltextzugriff (PDF)

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns

Thrombosis research, 2018-12, Vol.172, p.172-178

2018

Volltextzugriff (PDF)

A contribution to the debate on the laboratory criteria that define the antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2008-06, Vol.6 (6), p.1048-1049

PENGO, V.

2008

Volltextzugriff (PDF)

Thrombocytopenia in high‐risk patients with antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2018-03, Vol.16 (3), p.529-532

2018

Volltextzugriff (PDF)

Influence of different IgG anticardiolipin antibody cut‐off values on antiphospholipid syndrome classification

Journal of thrombosis and haemostasis, 2008-10, Vol.6 (10), p.1693-1696

2008

Volltextzugriff (PDF)

More on: laboratory investigation of lupus anticoagulants: mixing studies are sometimes required

Journal of thrombosis and haemostasis, 2011-10, Vol.9 (10), p.2126-2127

2011

Volltextzugriff (PDF)

Laboratory criteria for antiphospholipid syndrome: reply

Journal of thrombosis and haemostasis, 2018-10, Vol.16 (10), p.2117-2119

2018

Volltextzugriff (PDF)

Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non‐valvular atrial fibrillation

Journal of thrombosis and haemostasis, 2016-11, Vol.14 (11), p.2124-2131

2016

Volltextzugriff (PDF)

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile

Journal of thrombosis and haemostasis, 2013-08, Vol.11 (8), p.1527-1531

2013

Volltextzugriff (PDF)

1 – 25 von 272

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(244)
Mit Volltextzugriff
(214)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(175)
Science & Technology
(163)
Life Sciences & Biomedicine
(148)
Female
(118)
Male
(103)
Hematology
(82)
Middle Aged
(81)
Adult
(76)
Cardiovascular System & Cardiology
(74)
Peripheral Vascular Disease
(66)
Aged
(62)
Biological And Medical Sciences
(55)
Medical Sciences
(54)
Risk Factors
(41)
Antiphospholipid Syndrome
(40)
Anticoagulants - Therapeutic Use
(37)
Antiphospholipid Syndrome - Immunology
(36)
Thrombosis
(33)
Aged, 80 And Over
(32)
Anticoagulants - Administration & Dosage
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Thrombosis And Haemostasis
(47)
Thrombosis Research
(22)
Lupus
(20)
Thrombosis And Haemostasis
(20)
European Heart Journal
(12)
Blood
(7)
Haematologica
(7)
Ieee Transactions On Applied Superconductivity
(6)
Autoimmunity Reviews
(4)
Folia Haematologica
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma: comment

ISTH guidelines on Lupus Anticoagulant testing

Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH

Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk

Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants

Antiphospholipid syndrome: interpretation of laboratory data

ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study

Update of the guidelines for lupus anticoagulant detection

Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial

The role of platelets in antiphospholipid syndrome

McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome

The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns

A contribution to the debate on the laboratory criteria that define the antiphospholipid syndrome

Thrombocytopenia in high‐risk patients with antiphospholipid syndrome

Influence of different IgG anticardiolipin antibody cut‐off values on antiphospholipid syndrome classification

More on: laboratory investigation of lupus anticoagulants: mixing studies are sometimes required

Laboratory criteria for antiphospholipid syndrome: reply

Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non‐valvular atrial fibrillation

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile

Suchergebnisse filtern